Table 2.
Biomarker | Increase per month, relative to baseline | ||
---|---|---|---|
Mean | (95% CI) | P-value | |
Serum NfL (pg/mL) 1 | 0.98% | (0.57%, 1.38%) | <0.0001 |
| |||
Serum pNfH (pg/mL) 1 | 0.45% | (−0.12%, 1.03%) | 0.12 |
| |||
Serum NfL/pNfH ratio | 0.44% | (−0.09%, 0.97%) | 0.10 |
| |||
Urinary p75ECD (ng/mg creatinine) | 2.59% | (2.01%, 3.17%) | <0.0001 |
Values are unadjusted for core clinical covariates
One substantial outlier, from the 18-month visit (i.e. visit 5) of a participant, was excluded.